Navigation Links
Kroenke honored for outstanding contributions in clinical research training
Date:4/17/2012

INDIANAPOLIS Regenstrief Institute investigator Kurt Kroenke, M.D., will receive the 2012 Distinguished Educator Award, to be presented at Translational Science 2012 in Washington, D.C., April 18 to 20. Dr. Kroenke is also Chancellor's Professor of Medicine in the Indiana University School of Medicine and a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis.

Dr. Kroenke is being recognized as a clinical research training program innovator; for his outstanding success as a mentor; for his documented national leadership in clinical research education programs, issues and funding; and for a distinguished career as a clinical investigator.

He serves as director of fellowship and training programs at the Regenstrief Institute, director of the Indiana University Master of Science in Clinical Research Program and director of the Research Education, Training and Career Development Program at the Indiana Clinical and Translational Sciences Institute (CTSI).

The Translational Science 2012 awards committee was composed of representatives from the Association for Clinical Research Training, the American Federation for Medical Research, the Society for Clinical and Translational Science and the Association for Patient-Oriented Research.

Dr. Kroenke's clinical research focuses on the evaluation and management of common physical and psychological symptoms such as pain, fatigue, depression and anxiety. He has a particular interest in comparative effectiveness trials and in developing brief scales to assess and monitor symptoms.

A graduate of Valparaiso University, he attended medical school at Washington University in St. Louis and completed a residency in internal medicine at Tripler Army Medical Center. After serving two decades in the military, he retired from the U.S. Army Medical Corps as a colonel. He joined the Regenstrief Institute and Indiana University in 1997.

In addition to authoring more than 280 peer-reviewed publications and receiving numerous teaching awards, he is the recipient of sustained research funding from the National Institutes of Health, the Department of Veterans Affairs and other U.S. government agencies, foundations and industry. He is a past president of the Society of General Internal Medicine and the Association for Clinical Research Training, and a Master of the American College of Physicians.

"Dr. Kroenke embodies everything one imagines in an outstanding mentor: knowledge, wisdom and total dedication to helping young investigators become accomplished scientists. We are extremely fortunate to have him lead our education programs," said Anantha Shekhar, M.D., Ph.D., associate dean for translational research at the IU School of Medicine and director of the Indiana CTSI, which includes IU, Purdue University and the University of Notre Dame.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related medicine news :

1. Laser Spine Institute Honored at the Gridiron Greats Night of Champions
2. Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by United Chambers of Commerce
3. US Oncology Honored by Texas Governor Perrys Office with Inaugural Governors Business Hall of Fame Award
4. Elizabeth Colston, MD, PhD, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
5. Amerigroup CEO James Carlson Honored at Crystal Ball for a Cure Annual Gala
6. WebMD Health Foundation Honored as Leader in Health by CancerCare
7. Five Organizations Receive APAs Psychologically Healthy Workplace Award, Ten Honored for Best Practices
8. UBC scientist honored with BMJs Junior Doctor of the Year Award
9. JDRF Founder, Lee Ducat, To Be Honored at 40th Anniversary Gala in Philadelphia
10. Bright Horizons Honored as Company that Cares for Third Straight Year
11. Enovate Honored as One of the 2010 “Michigan 50 Companies to Watch”
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Kroenke honored for outstanding contributions in clinical research training
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: